Research projects

Kasper Rouschop Headshot

Active Netherlands

General cancer research

Could tailored therapies target cancers with a recycling problem?

Thanks to our Curestarters, Dr Rouschop is exploring a particular cancer cell vulnerability - their inability to recycle. He hopes to create tailored cancer therapies with fewer side effects. 

Researcher: Dr Kasper Rouschop

Could tailored therapies target cancers with a recycling problem?
Edurne Rujas Team

Active Spain

General cancer research

Can ‘2 in 1’ therapy improve how we treat cancer?

Our project in Spain is exploring an innovative new 'dual-action' cancer cure. Immunotherapy and chemotherapy are two cancer treatments - Dr Rujas has the bright idea of combining both therapies to create a new, better treatment for patients. 

Researcher: Dr Edurne Rujas

Can ‘2 in 1’ therapy improve how we treat cancer?
Mika Reinisalo Headshot

Active Finland

Retinoblastoma

Can nanoparticles make a big difference in retinoblastoma cancer?

Curestarter researcher Dr Mika Reinisalo is hoping to find a new way to treat retinoblastoma, a rare but deadly form of eye cancer that affects young children. He is exploring innovative boron therapy that should be kinder to patients. 

Researcher: Dr Mika Reinisalo

Can nanoparticles make a big difference in retinoblastoma cancer?
Luciano Di Croce Team Shot

Active Spain

Brain cancer

Can we find a cure for a rare childhood brain cancer?

Thanks to your help, Professor Luciano Di Croce in Spain is hoping to find a cure for a rare but aggressive type of childhood cancer. 

Researcher: Professor Luciano Di Croce

Can we find a cure for a rare childhood brain cancer?
Phillip Karpowicz Headshot

Active Canada

Bowel cancer

Does the time we eat affect bowel cancer development?

Dr Karpowicz believes one of the causes of bowel cancer could be that changes to our lifestyle disturb the circadian rhythm of our guts – and with the support of our Curestarters he will be able to test this idea. 

Researcher: Dr Phillip Karpowicz

Does the time we eat affect bowel cancer development?
Helder Maiato Headshot

Active Portugal

Breast cancer

Can we tackle drug resistance by de-coding the structure of cells?

Patients often respond well to chemotherapy only to later develop treatment resistance – meaning the cancer comes back and the chemotherapy has stopped working. Professor Maiato wants to find ways to prevent this treatment resistance.

Researcher: Professor Helder Maiato

Can we tackle drug resistance by de-coding the structure of cells?
Ana Cuenda Team Photo

Active Spain

Bowel cancer

Can healthy cells tell us how to stop bowel cancer spreading?

Our project in Spain co-funded with AECC is hoping to stop bowel cancer spreading. If we can understand more about how bowel cancer spreads, we can develop new and better ways to treat this type of disease.

Researcher: Dr Ana Cuenda

Can healthy cells tell us how to stop bowel cancer spreading?
Maria Alieva Headshot

Active Spain

Brain cancer

How can we stop childhood brain tumours being so aggressive?

Our project in Spain is looking for cures for the childhood tumour diffuse midline glioma (DMG). Dr Alieva hopes to find out more about how DMGs begin to grow, so that new treatments can be developed for this devastating disease. 

Researcher: Dr Maria Alieva

How can we stop childhood brain tumours being so aggressive?
Alessandra Ghigo Headshot

Active Italy

General cancer research

Can we reduce the risk of secondary cancer for people treated with chemotherapy?

Curestarter researcher Professor Ghigo is finding new ways to prevent long-term side effects of chemotherapy, and improve the lives of people who have been through cancer

Researcher: Professor Alessandra Ghigo

Can we reduce the risk of secondary cancer for people treated with chemotherapy?
We have funded over £220m of research worldwide since 1979 and cancer survival rates have doubled in that time. 

But global funding for discovery research has declined in recent years and we risk losing the cancer cures of the future. Your support can turn the tide. 

Why is discovery research important?

  • 90,436
    Curestarters & counting have helped us fund...
  • 123
    projects in the last five years. But we have had to turn down…
  • 136
    other top ideas due to lack of funding. That's more than...
  • 50%
    of these potential new cancer cures lost.
  • 917
    people chose to become a Curestarter last month. Join them so that one day…
  • 0
    lives will be cut short by cancer.

Donate today to start new cures

Be part of the united effort to stop lives being cut short by cancer.